308 related articles for article (PubMed ID: 26428309)
21. Movement disorders in the psychiatric patient.
Moros DA; Yahr MD
Hosp Community Psychiatry; 1984 Apr; 35(4):377-83. PubMed ID: 6232196
[TBL] [Abstract][Full Text] [Related]
22. Tremor and myoclonus.
Zutt R; Elting JW; Tijssen MAJ
Handb Clin Neurol; 2019; 161():149-165. PubMed ID: 31307597
[TBL] [Abstract][Full Text] [Related]
23. [Laboratory diagnosis of hyperkinetic movement disorders in adulthood].
Laubis-Herrmann U; Topka H
Nervenarzt; 2002 Feb; 73(2):133-43. PubMed ID: 11975089
[TBL] [Abstract][Full Text] [Related]
24. Definition and classification of hyperkinetic movements in childhood.
Sanger TD; Chen D; Fehlings DL; Hallett M; Lang AE; Mink JW; Singer HS; Alter K; Ben-Pazi H; Butler EE; Chen R; Collins A; Dayanidhi S; Forssberg H; Fowler E; Gilbert DL; Gorman SL; Gormley ME; Jinnah HA; Kornblau B; Krosschell KJ; Lehman RK; MacKinnon C; Malanga CJ; Mesterman R; Michaels MB; Pearson TS; Rose J; Russman BS; Sternad D; Swoboda KJ; Valero-Cuevas F
Mov Disord; 2010 Aug; 25(11):1538-49. PubMed ID: 20589866
[TBL] [Abstract][Full Text] [Related]
25. 6: Movement disorders II: the hyperkinetic disorders.
Rice JE; Thompson PD
Med J Aust; 2001 Apr; 174(8):413-9. PubMed ID: 11346089
[TBL] [Abstract][Full Text] [Related]
26. Tardive tremor.
Stacy M; Jankovic J
Mov Disord; 1992; 7(1):53-7. PubMed ID: 1348352
[TBL] [Abstract][Full Text] [Related]
27. Models of hyperkinetic disorders in primates.
Bezard E
J Neurosci Methods; 2020 Feb; 332():108551. PubMed ID: 31857131
[TBL] [Abstract][Full Text] [Related]
28. Hyperkinetic movement disorders following SARS-CoV-2 infection and vaccination - an update.
Przytuła F; Sławek J
Neurol Neurochir Pol; 2023; 57(1):63-76. PubMed ID: 36799521
[TBL] [Abstract][Full Text] [Related]
29. Drug-induced hyperkinetic movement disorders by nonneuroleptic agents.
Zesiewicz TA; Sullivan KL
Handb Clin Neurol; 2011; 100():347-63. PubMed ID: 21496594
[TBL] [Abstract][Full Text] [Related]
30. How can neurophysiological studies help with movement disorders characterization in clinical practice? A review.
Grippe T; Cunha NSCD; BrandÃo PRP; Fernandez RNM; Cardoso FEC
Arq Neuropsiquiatr; 2020 May; 78(8):512-522. PubMed ID: 32901697
[TBL] [Abstract][Full Text] [Related]
31. The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders.
Pérez-Dueñas B; Gorman K; Marcé-Grau A; Ortigoza-Escobar JD; Macaya A; Danti FR; Barwick K; Papandreou A; Ng J; Meyer E; Mohammad SS; Smith M; Muntoni F; Munot P; Uusimaa J; Vieira P; Sheridan E; Guerrini R; Cobben J; Yilmaz S; De Grandis E; Dale RC; Pons R; Peall KJ; Leuzzi V; Kurian MA
Mov Disord; 2022 Nov; 37(11):2197-2209. PubMed ID: 36054588
[TBL] [Abstract][Full Text] [Related]
32. Botulinum neurotoxins for the treatment of focal dystonias: Review of rating tools used in clinical trials.
Del Sorbo F; Albanese A
Toxicon; 2015 Dec; 107(Pt A):89-97. PubMed ID: 26365917
[TBL] [Abstract][Full Text] [Related]
33. Myoclonus and Dystonia as Recurrent Presenting Features in Patients with the SCA21-Associated
Sorrentino U; Romito LM; Garavaglia B; Fichera M; Colangelo I; Prokisch H; Winkelmann J; Necpal J; Jech R; Zech M
Tremor Other Hyperkinet Mov (N Y); 2024; 14():16. PubMed ID: 38617829
[TBL] [Abstract][Full Text] [Related]
34. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders.
Kenney C; Hunter C; Jankovic J
Mov Disord; 2007 Jan; 22(2):193-7. PubMed ID: 17133512
[TBL] [Abstract][Full Text] [Related]
35. Functional tics: Expanding the phenotypes of functional movement disorders?
Cavanna AE; Purpura G; Riva A; Nacinovich R; Seri S
Eur J Neurol; 2023 Oct; 30(10):3353-3356. PubMed ID: 37410535
[TBL] [Abstract][Full Text] [Related]
36. Task force report: scales for screening and evaluating tremor: critique and recommendations.
Elble R; Bain P; Forjaz MJ; Haubenberger D; Testa C; Goetz CG; Leentjens AF; Martinez-Martin P; Pavy-Le Traon A; Post B; Sampaio C; Stebbins GT; Weintraub D; Schrag A
Mov Disord; 2013 Nov; 28(13):1793-800. PubMed ID: 24038576
[TBL] [Abstract][Full Text] [Related]
37. Treatment of psychiatric disturbances in common hyperkinetic movement disorders.
Berardelli I; Pasquini M; Conte A; Bologna M; Berardelli A; Fabbrini G
Expert Rev Neurother; 2019 Jan; 19(1):55-65. PubMed ID: 30501439
[No Abstract] [Full Text] [Related]
38. Next move in movement disorders (NEMO): developing a computer-aided classification tool for hyperkinetic movement disorders.
van der Stouwe AMM; Tuitert I; Giotis I; Calon J; Gannamani R; Dalenberg JR; van der Veen S; Klamer MR; Telea AC; Tijssen MAJ
BMJ Open; 2021 Oct; 11(10):e055068. PubMed ID: 34635535
[TBL] [Abstract][Full Text] [Related]
39. The eye of the beholder: inter-rater agreement among experts on psychogenic jerky movement disorders.
van der Salm SM; de Haan RJ; Cath DC; van Rootselaar AF; Tijssen MA
J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):742-7. PubMed ID: 23412076
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hyperkinetic movement disorders.
Jankovic J
Lancet Neurol; 2009 Sep; 8(9):844-56. PubMed ID: 19679276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
